MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Please note there are other MPT candidates not listed that may move forward pending funding. Click here to learn more about the inclusion criteria and information update methodology.
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!
Click on the table for MPT products in the development pipeline by indication combination.
Hormonal/Non-HormonalDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

25 product(s) found

Results: 2 product(s) found
EFdA-P + Progestin Intravaginal Film
MPT in Development
Hormonal Topical Film - Vaginal
  • 4'-Ethynyl-2-fluoro-2'-deoxyadenosine prodrug (EFdA-P)
  • Progestin
  • Magee-Women's Research Inst. & Foundation
  • Pre1
  • HIV
  • Pregnancy
  • MB66 Film
    MPT in Development
    Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • C1
  • HIV
  • HSV-2
  • IMPT Secretariat
    1750 Howe Avenue, Suite 550
    Sacramento, CA 95825
    IMPT@cami-health.org

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated to advancing the comprehensive sexual and reproductive health of women and girls worldwide. CAMI Health is housed at the Public Health Institute (PHI).

    © Copyright 2020, Public Health Institute / CAMI Health / IMPT Secretariat. All rights reserved.